Loading
Novan, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BIERMAN JAMES L, was filed 11 Apr 2022.
Novan, Inc.: what insiders have been doing
Every trade that managers of Novan, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. No insider at Novan, Inc. has published a filing in the past twelve months. The most recent one dates from 27 June 2023.
Over the whole record (from 2018), the tally stands at 20 purchases and 4 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
30
Thresholds
n/a
Buy Volume
€584,524
20 ops. · all time
Sell Volume
€63,932
4 ops. · all time
Since the insiders bought
- +18.6%Entry 131.61 · Close at T+365 156.13
- +4.8%Entry 142.20 · Close at T+365 149.05
- +4.8%Entry 142.20 · Close at T+365 149.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 27 June 2023
Declarations30 total
11,553 shares@ US$0.4082100.0% of flowCommon StockSEC:0001467154-23-000073:0
65,000 shares0Common StockSEC:0001467154-23-000065:0
36,101 shares0Common StockSEC:0001467154-23-000063:0
36,101 shares0Common StockSEC:0001467154-23-000064:0
36,101 shares0Common StockSEC:0001467154-23-000061:0
36,101 shares0Common StockSEC:0001467154-23-000060:0
36,101 shares0Common StockSEC:0001467154-23-000062:0
1,000 shares@ US$3.448824.9% of flowCommon StockSEC:0001467154-22-000054:0
Canonical exit: 6 Jul 2022 (T+90)
1,000 shares@ US$3.4524.6% of flowCommon StockSEC:0001467154-22-000047:0
Canonical exit: 26 Jun 2022 (T+90)
2,000 shares@ US$3.54550.5% of flowCommon StockSEC:0001467154-22-000045:0
Canonical exit: 23 Jun 2022 (T+90)
1,000 shares@ US$3.50100.0% of flowCommon StockSEC:0001467154-22-000042:0
Canonical exit: 16 Jun 2022 (T+90)
10,000 shares@ US$3.63568.3% of flowCommon StockSEC:0001467154-22-000043:0
Canonical exit: 16 Jun 2022 (T+90)
5,000 shares@ US$3.33731.7% of flowCommon StockSEC:0001467154-22-000039:0
Canonical exit: 14 Jun 2022 (T+90)
7,000 sharesCommon StockSEC:0001467154-20-000028:0
Canonical exit: 1 Jun 2020 (T+90)
200,000 sharesCommon StockSEC:0001467154-20-000029:0
Canonical exit: 1 Jun 2020 (T+90)
17,800 shares@ US$2.69Common StockSEC:0001104659-19-039167:0
913 shares@ US$2.74Common StockSEC:0001104659-19-039167:1
6,287 shares@ US$2.75Common StockSEC:0001104659-19-039167:2
1,500 shares@ US$1.97Common StockSEC:0001467154-19-000046:0
Canonical exit: 27 Aug 2019 (T+90)
3,500 shares@ US$2.15Common StockSEC:0001467154-19-000044:0
Canonical exit: 26 Aug 2019 (T+90)
20,000 shares@ US$2.20Common StockSEC:0001467154-19-000043:0
Canonical exit: 22 Aug 2019 (T+90)
5,000 shares@ US$1.90Common StockSEC:0001467154-19-000040:0
Canonical exit: 19 Aug 2019 (T+90)
50,000 shares@ US$2.21Common StockSEC:0001467154-19-000039:0
Canonical exit: 20 Aug 2019 (T+90)
20,000 shares@ US$1.43Common StockSEC:0001467154-19-000033:0
Canonical exit: 15 Aug 2019 (T+90)
40,000 shares@ US$1.43Common StockSEC:0001467154-19-000033:1
Canonical exit: 15 Aug 2019 (T+90)
25 of 30 declarations
About Novan, Inc.
Novan, Inc. is a company focused on developing innovative treatments for dermatological diseases. It specializes in the use of nitric oxide technology for its products.
